Scientists develop novel technology to identify biomarkers for ulcerative colitis

October 3, 2012

Scientists from the Florida campus of The Scripps Research Institute have developed a novel technology that can identify, in animal models, potential biomarkers of ulcerative colitis, a type of inflammatory bowel disease that affects the lining of the colon.

The study was published October 3, 2012, in the .

The new research focuses on the protein arginine deiminases (PAD), which have been implicated in a number of diseases, including cancer, multiple sclerosis and rheumatoid arthritis. PADs participate in reactions in the body that form the amino acid citrulline in proteins through a process known as citrullination. This modification can have significant effects on the structure and function of the modified proteins.

While abnormally high PAD activity is present in a host of human diseases, the exact role of citrullination in these diseases remains unknown, largely due to the lack of readily available chemical probes to study it.

"We have developed technology to identify biomarkers for a variety of diseases in which you see abnormal PAD activity," said Paul Thompson, an associate professor in the Department of Chemistry at Scripps Research, who led the study. "This identification of potential biomarkers in animal models of ulcerative colitis is really the first step in a much larger effort. We want to push forward into and cancer to look for different diagnostic markers in these disease situations."

In the new study, the scientists describe a chemical probe called rhodamine‐phenylglyoxal (Rh‐PG), which tags citrulline-containing proteins with a fluorescent imaging compound.

According to Thompson, the next step will be to produce further generations of this to isolate the biomarker proteins and determine their sites of modification, as well as to quantify the extent of the citrullination.

Explore further: Steroids prevent protein changes seen in the joints of people with rheumatoid arthritis

More information: "Seeing Citrulline: Development of a Phenylglyoxal‐Based Probe to Visualize Protein Citrullination," pubs.acs.org/doi/abs/10.1021/ja308871v

Related Stories

Steroids prevent protein changes seen in the joints of people with rheumatoid arthritis

January 27, 2012
Rheumatoid arthritis (RA) is a chronic inflammatory disease where the body begins to attack the joints and organs of the body. Proteins within inflamed joints are often modified by citrullination, a process that converts ...

Team pinpoints amino acid variation in immune response gene linked with ulcerative colitis

December 15, 2011
The association between the inflammatory bowel disease ulcerative colitis and a gene that makes certain cell surface proteins has been pinpointed to a variant amino acid in a crucial binding site that profoundly influences ...

Gene associated with ulcerative colitis uncovered by researchers

August 3, 2011
For as long as seven-year-old Jonathan Wexler can remember, he has taken sweet orange medicine every day to manage his ulcerative colitis symptoms. When he was only eight months old, Jonathan became the youngest patient to ...

Recommended for you

New insights into protein's role in inflammatory response

July 28, 2017
A protein called POP2 inhibits a key inflammatory pathway, calming the body's inflammatory response before it can become destructive, Northwestern Medicine scientists have demonstrated in mouse models.

Targeting 'broken' metabolism in immune cells reduces inflammatory disease

July 12, 2017
The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune ...

A perturbed skin microbiome can be 'contagious' and promote inflammation, study finds

June 29, 2017
Even in healthy individuals, the skin plays host to a menagerie of bacteria, fungi and viruses. Growing scientific evidence suggests that this lively community, collectively known as the skin microbiome, serves an important ...

Inflammatory bowel disease: Scientists zoom in on genetic culprits

June 28, 2017
Scientists have closed in on specific genes responsible for Inflammatory Bowel Disease (IBD) from a list of over 600 genes that were suspects for the disease. The team from the Wellcome Trust Sanger Institute and their collaborators ...

Trials show unique stem cells a potential asthma treatment

June 28, 2017
A study led by scientists at Monash University has shown that a new therapy developed through stem cell technology holds promise as a treatment for chronic asthma.

Researchers find piece in inflammatory disease puzzle

May 23, 2017
Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.